The global poultry vaccines market reached a value of US$ 1.67 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.47 Billion by 2027, exhibiting at a CAGR of 6.59% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Poultry disease is an infectious animal disease affecting poultry species, such as duck, chicken, turkey, and goose. It causes facial edema, diarrhea, twisting of neck and paralysis of wings and legs, cyanosis of comb, reduction in egg production, and sudden death. As a result, poultry animals undergo vaccination to stimulate their immune mechanism and produce antibodies, which inactivates pathogens. The vaccination also assists in preserving the productive health of these animals by acting as a protective measure against the outbreak of contagious diseases. At present, it can be administered via injections, feed, eye-drop, and drinking water.

Poultry Vaccines Market Trends:
There is currently an increase in the prevalence of zoonotic diseases like avian influenza or bird flu that spreads among animals and infects humans. This, along with the escalating demand for animal health diagnostics, represents one of the key factors strengthening the growth of the market. Apart from this, the increasing consumption of animal-derived products and rising concerns about food safety around the world are contributing to market growth. Furthermore, leading market players are considerably investing in research and development (R&D) activities to introduce poultry vaccines that help protect against avian diseases, such as infectious bronchitis, infectious bursal diseases, and virulent Newcastle disease (VND). They are also utilizing advanced technologies to manufacture effective vaccines, which is creating a favorable market outlook. Besides this, the growing awareness among veterinary practitioners about animal vaccination is positively influencing the market. Other major factors, including a significant rise in the spending on animal health worldwide, an increase in the poultry population, and the introduction of live, non-replicating recombinant antigens, nucleic acid-mediated, and live-gene detected vaccines, are projected to drive the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global poultry vaccines market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on disease, product, dosage form, application and end user.

Breakup by Disease:

  • Infectious Bronchitis
  • Avian Influenza
  • Newcastle Disease
  • Marek’s Disease
  • Others


Breakup by Product:

  • Recombinant Vaccine
  • Live Attenuated Vaccine
  • Inactivated Vaccine
  • Subunit Vaccine
  • Others


Breakup by Dosage Form:

  • Liquid Vaccine
  • Freeze Dried Vaccine


Breakup by Application:

  • Breeder
  • Broiler
  • Layer


Breakup by End User:

  • Veterinary Hospitals
  • Poultry Firm
  • Poultry Vaccination Center


Breakup by Region:

North America

  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others

Latin America

  • Brazil
  • Mexico
  • Others

Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AniCon Labor GmbH (SAN Group), Biovac Ltd., Boehringer Ingelheim International GmbH, Ceva Sant? Animale, Elanco, Hester Biosciences Limited, Merck & Co. Inc., Phibro Animal Health Corporation, Venkys India and Zoetis Inc.

Key Questions Answered in This Report:

  • How has the global poultry vaccines market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global poultry vaccines market?
  • What are the key regional markets?
  • What is the breakup of the market based on the disease?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the dosage form?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global poultry vaccines market and who are the key players?
  • What is the degree of competition in the industry?